Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 1Phase 2 Interventional

Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers

ClinicalTrials.gov ID: NCT00316537

Public ClinicalTrials.gov record NCT00316537. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Study of the Safety and Preliminary Efficacy of Low-Dose Nicotine Gel (ATG002) in Patients With Plantar Diabetic Foot Ulcers

Study identification

NCT ID
NCT00316537
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
CoMentis
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

  • ATG002 (study drug) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Not listed
Completion
Jun 30, 2007
Last update posted
Aug 8, 2007

2006 – 2007

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
SeniorCare, Alabama Geriatric Specialists Homewood Alabama 35209
Hope Research Institute Phoenix Arizona 85050
Southern Arizona VA Health Care System Tucson Arizona 85723
Center for Clinical Research Castro Valley California 94546
University of San Diego Wound Treatment and Research Center San Diego California 92103
University of Miami Miami Florida 33136
Ankle and Foot Specialists of Atlanta Lithonia Georgia 30058
Crossroads Research, Inc. Owings Mills Maryland 21117
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
NewBridge Medical Research Warren Pennsylvania 16365
Central Washington Podiatry Service Yakima Washington 98902
Aurora Health Care / Lukes Medical Center Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00316537, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2007 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00316537 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →